Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis
MAFLD increased the risk of COVID-19 disease severity, with a pooled OR of 2.93 (95CI 1.87, 4.60, I2 = 34.3%, P = 0.166) In this meta-analysis, we found that a high percentage of patients with the coronavirus disease 2019 had MAFLD.